Title : Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients.

Pub. Date : 2015 Jun 19

PMID : 26087958






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Significant improvements in apoB were seen with both ezetimibe plus rosuvastatin (mean of -0.17 g/L, p < 0.001) and rosuvastatin 20 mg (mean of -0.13 g/L, p = 0.03) treatment groups, but did not differ between groups (p = 0.53). Rosuvastatin Calcium apolipoprotein B Homo sapiens
2 Significant improvements in apoB were seen with both ezetimibe plus rosuvastatin (mean of -0.17 g/L, p < 0.001) and rosuvastatin 20 mg (mean of -0.13 g/L, p = 0.03) treatment groups, but did not differ between groups (p = 0.53). Rosuvastatin Calcium apolipoprotein B Homo sapiens